Internal Medicine, Rheumatology · Vineland, NJ
NPI
1801148697
Since 2012
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2848 S Delsea Dr, Ste 2c
Vineland, NJ, 08360
Phone (856) 794-9090
Groups this clinician bills Medicare through
Medicare paid, 2024
$235K
54,574 services
Medicare patients, 2024
463
Average age 70
Drug cost, 2024
$1.6M
5,849 prescriptions
Company payments, 2025
$883
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew R Arkebauer was code J1010 (injection, methylprednisolone acetate, 1 mg), 42,342 times for 220 patients. In total Matthew R Arkebauer billed 54,574 services in 63 codes, and Medicare paid $235K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 42,342 | 220 | $0.10 | $4,282 |
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 19 | $19.91 | $27K |
| 99213 Office E&M - Established | Office | 786 | 398 | $59.55 | $47K |
| 20610 Joint Injection | Office | 393 | 188 | $56.27 | $22K |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 253 | 124 | $5.74 | $1,453 |
| 77080 Standard X-ray | Office | 148 | 148 | $37.08 | $5,487 |
| 99214 Office E&M - Established | Office | 112 | 78 | $87.02 | $9,746 |
| 20550 Musculoskeletal | Office | 107 | 69 | $36.37 | $3,892 |
| 20600 Joint Injection | Office | 95 | 61 | $39.44 | $3,747 |
| 73560 X-ray - Lower Extremity | Office | 84 | 46 | $25.90 | $2,175 |
| 73120 X-ray - Upper Extremity | Office | 72 | 37 | $22.52 | $1,621 |
| 73100 X-ray - Upper Extremity | Office | 66 | 34 | $24.93 | $1,645 |
| 73030 X-ray - Upper Extremity | Office | 56 | 31 | $25.19 | $1,410 |
| 20605 Joint Injection | Office | 46 | 37 | $37.03 | $1,704 |
| 72110 X-ray - Spine and Pelvis | Office | 33 | 33 | $39.25 | $1,295 |
By year: 2022 $364K for 21,394 services; 2023 $795K for 52,698 services; 2024 $235K for 54,574 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew R Arkebauer prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,582 prescriptions and refills. In total Matthew R Arkebauer wrote 5,849 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,582 | 2,650 | 317 | $35K |
| Methylprednisolone Generic | 997 | 1,701 | 262 | $17K |
| Tramadol Hcl Generic | 602 | 606 | 107 | $5,511 |
| Hydroxychloroquine Sulfate Generic | 373 | 753 | 91 | $14K |
| Prednisone Generic | 309 | 526 | 72 | $1,772 |
| Allopurinol Generic | 259 | 615 | 62 | $3,326 |
| Gabapentin Generic | 212 | 369 | 55 | $4,789 |
| Pregabalin Generic | 145 | 198 | 32 | $2,964 |
| Zolpidem Tartrate Generic | 127 | 167 | 25 | $916 |
| Duloxetine Hcl Generic | 90 | 186 | 24 | $2,499 |
| Amitriptyline Hcl Generic | 87 | 163 | 22 | $1,042 |
| Baclofen Generic | 84 | 110 | 32 | $619 |
| Folic Acid Generic | 84 | 224 | 24 | $1,103 |
| Meloxicam Generic | 72 | 148 | 17 | $315 |
| Enbrel Sureclick Etanercept | 62 | 63 | Under 11 | $444K |
Brand drugs: - claims; generic drugs: 5,595 claims; opioid claims: 616.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew R Arkebauer $883 ($883 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $261.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 13 | $261 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $157 |
| Abbvie Inc. ABBV | 10 | $137 |
| GlaxoSmithKline, LLC. GSK | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $39.83 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $33.84 |
| Amgen Inc. AMGN | 2 | $29.36 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $20.25 |
| Sandoz Inc. SDZ.SW | 1 | $19.45 |
| Invivyd Inc IVVD | 1 | $18.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.